In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates.
about
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosisUnderstanding nontuberculous mycobacterial lung disease: it's been a long time comingPulmonary Disease Due to Nontuberculous Mycobacteria: Current State and New InsightsThe Challenge of Pulmonary Nontuberculous Mycobacterial Infection.Pulmonary Deposition and Elimination of Liposomal Amikacin for Inhalation and Effect on Macrophage Function after Administration in RatsClinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung DiseaseDrug susceptibility testing of nontuberculous mycobacteria.Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of view.Antibiotic treatment for nontuberculous mycobacterial lung disease.Treatment of Non-Tuberculous Mycobacterial Lung Disease.Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.In Vitro Susceptibility Testing of Tedizolid against Nontuberculous Mycobacteria.A Breath of Fresh Air for Patients with Pulmonary Nontuberculous Mycobacterial Infection.Emergence of mmpT5 Variants during Bedaquiline Treatment of Mycobacterium intracellulare Lung DiseaseRandomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease.[Nontuberculous mycobacterial pulmonary disease]."You can't always get what you want…" the Mycobacterium abscessus issue. Name versus function.Significant difference in drug susceptibility distribution between Mycobacterium avium and Mycobacterium intracellulare.Assessing primary and secondary resistance to clarithromycin and amikacin in infections due to Mycobacterium avium complex.Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages.MIC Values of Rifampin and Ethambutol and Treatment Outcome in Mycobacterium avium Complex Lung Disease
P2860
Q26775974-A3D8830A-977E-44CA-BA03-8DDA9E6E14B7Q28071355-8744E083-1EBA-49D0-90C7-B59735F8EA25Q28087593-CCD70AC7-647F-40F9-B50C-764FBC392885Q36567746-D8EDF655-1434-4044-94DF-CE597E1685A7Q37358621-DE40E601-111E-4C07-8802-CDB0B0D677E7Q37358685-100CD0F9-0AD4-4C13-AF9F-57BA157D866EQ38262208-20E32912-EF01-41AF-8D27-7D1D848C9D14Q38581888-EBD2B09C-4C19-4C9E-BAFB-C9E960A06594Q38770072-305D7701-73CB-48A9-BC94-8EFF882F3D68Q39321216-F2BBA40F-12B4-456B-8087-ACD2D8A17DBAQ40281966-A6B59971-ECD3-41E8-A0F1-EC7092B7F172Q40283050-81B120F2-6C4A-4D4A-858E-D36F71E296EEQ40293783-E965B4AE-B4A7-4976-A7FE-BEA9A4251AB6Q40419592-C4E52DEA-8CB1-4950-AB3B-33C71270E50BQ40504302-80115993-6A54-41EA-821E-3D7745148343Q40818353-E98F1E64-B823-4EEC-B5E1-463E90616AE9Q42576246-F2DFBAA0-8E6F-4419-8D0E-536CB9DB8A1FQ43126100-9FED9E80-0CF3-4E90-9A18-FDD70DD429F5Q43223526-E5479E33-7814-449D-A498-B849473FAA09Q55057435-7B05A02A-7C5A-453E-A0C4-CCBEE05CD0BBQ57210549-27A25F21-585F-4996-A220-8106386292FF
P2860
In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vitro activity of amikacin ...... mutation in treated isolates.
@en
In vitro activity of amikacin ...... mutation in treated isolates.
@nl
type
label
In vitro activity of amikacin ...... mutation in treated isolates.
@en
In vitro activity of amikacin ...... mutation in treated isolates.
@nl
prefLabel
In vitro activity of amikacin ...... mutation in treated isolates.
@en
In vitro activity of amikacin ...... mutation in treated isolates.
@nl
P2093
P2860
P356
P1476
In vitro activity of amikacin ...... mutation in treated isolates.
@en
P2093
Barbara A Brown-Elliott
Cameron R Wolfe
Christine Y Turenne
David E Griffith
Elena Iakhiaeva
Gail L Woods
Jason E Stout
Richard J Wallace
P2860
P304
P356
10.1128/JCM.01612-13
P407
P577
2013-08-14T00:00:00Z